PharVision Advisers’s Repay Holdings RPAY Stock Holding History

PharVision Advisers’s Portfolio RPAY Stock Details RPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,814	Closed	-$38.5K	–	120
2026 Q1	$38.5K	Buy	+14,814	New	+$47.4K	0.39%	97
2025 Q4	–	Sell	-27,759	Closed	-$145K	–	963
2025 Q3	$145K	Buy	+27,759	New	+$149K	0.08%	576
2025 Q1	–	Sell	-14,975	Closed	-$114K	–	479
2024 Q4	$114K	Buy	+14,975	New	+$120K	0.1%	366

Other funds holding RPAY

FCM

Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return

VCM

Veradace Capital Management Dallas, Texas $132M AUM

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PharVision Advisers's RPAY Position: Q2 2026 in Review

PharVision Advisers sold out of Repay Holdings (RPAY) in Q2 2026, closing a stake of 14,814 shares — an estimated $38.5K sold.

PharVision Advisers first reported a position in RPAY in Q4 2024 and held it in 3 quarters. The position peaked at $145K in Q3 2025. 141 funds tracked by Wall St. Rank hold RPAY as of Q2 2026.

PharVision Advisers reported no remaining Repay Holdings position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 14,814 Repay Holdings shares in Q2 2026, an estimated $38.5K.
PharVision Advisers first reported a position in Repay Holdings in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Repay Holdings position peaked at $145K in Q3 2025.
141 funds tracked by Wall St. Rank held Repay Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.